Navigation Links
AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2007
Date:2/28/2008

of discontinued

operations, net of taxes of $230 - - - 230

Net loss $(902) $(1,146) $(862)$(1,024)

Loss per share

Basic:

Continuing operations $(0.02) $(0.03) $(0.02) $(0.03)

Discontinued operations 0.00 0.00 0.00 0.00

$(0.02) $(0.03) $(0.02) $(0.03)

Diluted:

Continuing operations $(0.02) $(0.03) $(0.02) $(0.03)

Discontinued operations 0.00 0.00 0.00 0.00

$(0.02) $(0.03) $(0.02) $(0.03)

Weighted average number of shares

outstanding:

Basic 44,746 45,135 44,657 46,499

Diluted 44,746 45,135 44,657 46,499

(a) - includes $30,000, $107,000, $17,000 and $54,000 in stock-based

compensation expense for the three and twelve months ended

December 31, 2007 and December 31, 2006, respectively.

(b) - includes $0.2 million, $1.5 million, $0.3 million and $1.5 million

in stock-based compensation expense for the three and twelve months

ended December 31, 2007 and December 31, 2006, respectively

(c) - includes $67,000, $267,000, $55,000 and $196,000 in stock-based

compensation expense for the three and twelve months ended

December 31, 2007 and December 31, 2006, respectively.

CONDENSED Consolidated Statements Of Cash Flows

(in thousands)

Twelve Months

Ended

December 31,


'/>"/>

SOURCE AMICAS, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. AMICAS Schedules Fourth Quarter and 2007 Year End Earnings Results Conference Call
2. AMICAS to Present at UBS Global Healthcare Services Conference
3. MedQuest Standardizes on AMICAS Vision Series PACS
4. AMICAS Solutions Closing the Loop in Radiology Communications
5. AMICAS Transforms Critical Results Notification with RadStream
6. AMICAS Launches Vision Reach 2.0, a Tool to Help Radiology Businesses Grow
7. Webcast Alert: AMICAS, Inc. Announces 3rd Quarter 2007 Earnings Conference Call
8. Radiology Ltd. Chooses AMICAS as End-to-End Solutions Provider
9. AMICAS Schedules Third Quarter Earnings Call
10. AMICAS to Present at William Blair & Company Small Cap Growth Stock Conference
11. AMICAS Hosts Complimentary DRA Education Session Featuring Timothy Trysla
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)... Radiation may have caused chromosomal change tha... , FRIDAY, Aug. 29 (HealthDay News) -- Some Jap...asts in Hiroshima and Nagasaki experienced key gen...form of thyroid cancer, new research indicates. ,...ked to a particular genetic mutation involving the...
(Date:8/29/2008)... HILLMAN, Mich., Aug. 29 /PRNewswire/ -- In r...tified case of chronic wasting disease (CWD),memb...following statement., With hunting season fast ap...itive test for a deer on a Kent County farm unders...r enthusiasts and deer farmers across,the great st...
(Date:8/29/2008)... CE Mark Opens Market to More Than 30 E... -- Hoana Medical, Inc. announced today,that it ha...audits for ISO,13485 and the Medical Device Direct...ows the use of the coveted CE Mark -- or Conformit...gilance System. This expands Hoana,s,patient safet...
(Date:8/29/2008)... , AMD presents Telemedic...tic leadership and State delegations as a possible... N.Chelmsford, MA (PRWEB) Augu...t message offered by the speakers at the Democrati...rm initiative to resolve our national health care ...
Breaking Medicine News(10 mins):Health News:Some Hiroshima Survivors at Thyroid Cancer Risk 2Health News:Some Hiroshima Survivors at Thyroid Cancer Risk 3Health News:Deer Farm Industry in Michigan Issues Statement on the Recent Chronic Wasting Disease Case Identified on a Kent County Deer Farm 2Health News:Hoana Medical Acquires CE Mark to Expand Patient Safety Technology to European Market 2Health News:Hoana Medical Acquires CE Mark to Expand Patient Safety Technology to European Market 3Health News:Hoana Medical Acquires CE Mark to Expand Patient Safety Technology to European Market 4Health News:AMD Global Telemedicine Inc. Invited to Attend Democratic National Convention 2
...wn death say they are more prepared than other doc...ther medical treatment is considered futile,// rev...l & Neonatal Edition of Archives of Disease in Chi... anonymous survey of 138 doctors specialising in t...
...orst hit by the flu pandemic, has stopped sharing ... H5N1 bird flu with foreign laboratories last// mo...ernational efforts to fight the highly pathogenic ...property rights ahead of a planned vaccine tie-up ...
...ters, of the Fred Hutchinson Cancer Research Cente...ings that show serum selenium or levels of seleniu... with reduced risks of prostate cancer as previous...rted that the mineral is associated with reducing ...
...adliest disease in the United States and a growing...evidence that chiropractic adjustments might be// ... program of wellness care to help diabetes suffere...of Vertebral Subluxation Research, focused on the ...
Other Medicine News:Health News:Doctors’ Own Fear of Death Linked to Hastening Death of Very Sick Newborn 2Health News:Higher Serum Selenium Linked With Reduced Risks of Prostate Cancer - in Some Men 2Health News:Research Explores Chiropractic's Effect on Diabetes 2
(Date:8/28/2008)... their 11- and 12-year-olds from,meningitis, whoop...er, ATLANTA, Aug 28 /PRNewswire-USNewswire/ -- Th...C) National Center for Immunization and,Respirator... announcements,(PSAs) targeting the parents of pre...s. The television and radio spots, part of CDC,s P...
(Date:8/27/2008)...cks, Delaware, Montgomery,Philadelphia Counties, ...-- After encouraging,results following the first n...onmental Protection will continue its efforts this...o-borne West Nile virus., Targeted aerial treatme...ht in portions of Bucks, Delaware, Montgomery and ...
(Date:8/27/2008)...ter at The Children,s Hospital at, Montefiore Pr...are and Specialty Servic...eats Every Heart Condition, NEW YORK, Aug. 27 /PR...,Montefiore (CHAM) is bringing the medical miracle...following the recent approval of its,transplant ce...
(Date:8/26/2008)...Semafore Pharmaceuticals Inc.,presented data at th...pies,in Cancer in Washington, D.C., announcing the...rs that demonstrate significant anticancer,activit...y molecular scaffold has been developed using,comp...PI3 kinase inhibitors,as well as isoform-selective...
Breaking Medicine Technology:DEP to Complete Aerial Mosquito Treatments to Stem West Nile Virus in Southeastern Counties 2DEP to Complete Aerial Mosquito Treatments to Stem West Nile Virus in Southeastern Counties 3Pediatric Heart Transplants at Montefiore Approved by NY State Department of Health 2Pediatric Heart Transplants at Montefiore Approved by NY State Department of Health 3Pediatric Heart Transplants at Montefiore Approved by NY State Department of Health 4Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 2Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 3Easter Seals Receives 241 Million Donation From CVS Caremark Charitable Trust to Enhance Autism Services for Children 16554 1Easter Seals Receives 241 Million Donation From CVS Caremark Charitable Trust to Enhance Autism Services for Children 16554 2Easter Seals Receives 241 Million Donation From CVS Caremark Charitable Trust to Enhance Autism Services for Children 16554 3North America Primed for Pet Insurance Market Expansion and Expecting 241 1 Billion by 2012 16552 1North America Primed for Pet Insurance Market Expansion and Expecting 241 1 Billion by 2012 16552 2Atherosclerosis May Also Harm Vital Organs 16549 1Atherosclerosis May Also Harm Vital Organs 16549 2Atherosclerosis May Also Harm Vital Organs 16549 3CardioDynamics Reports 22 25 Revenue Growth in First Quarter 2008 16545 1CardioDynamics Reports 22 25 Revenue Growth in First Quarter 2008 16545 2CardioDynamics Reports 22 25 Revenue Growth in First Quarter 2008 16545 3CardioDynamics Reports 22 25 Revenue Growth in First Quarter 2008 16545 4CardioDynamics Reports 22 25 Revenue Growth in First Quarter 2008 16545 5CardioDynamics Reports 22 25 Revenue Growth in First Quarter 2008 16545 6
...Company Launches 1,000-Patient Lung Cancer Diversi...Call/ -- Statistics show,lung cancer is the leadin... 21,550 new cases expected to be diagnosed,and 16,...ing, lung,cancer is the leading cause of cancer de...f cancer death in Hispanic women.(ii),Researchers ...
...Seven year follow up of pivotal trial confirms tha...ASEL, Switzerland, June 4, 2007-A follow-up analys...e non-Hodgkin,s lymphoma,(NHL) who were treated wi...ab) over seven years ago has revealed exciting res...phase III study has shown,that over half (53%) of ...
Other Medicine Technology:Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 2Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 3Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 4Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 5Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 6Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 7Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 8Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 9Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 10Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 11MabThera Significantly Extends Survival And Cures More Patients,With Aggressive Lymphoma Than Chemotherapy Alone 2MabThera Significantly Extends Survival And Cures More Patients,With Aggressive Lymphoma Than Chemotherapy Alone 3MabThera Significantly Extends Survival And Cures More Patients,With Aggressive Lymphoma Than Chemotherapy Alone 4
Ascent Primary Knee System with cruciate retaining, posterior stabilized and constrained components
The revision knee system for severe joint deterioration with insufficient ligament support.
The BioPro Total Knee system was developed to provide anatomical replacement of all articulating surfaces in the knee joint, while preserving the stabilizing Anterior and Posterior Ligaments, bone st
The NexGen Legacy LPS Femoral Component is intended for patients who, in the surgeon's judgement, have adequate bone stock and varus/valgus stability, and/or when the surgeon elects to substitute for
Medicine Products: